why choose us

First received: July 25, 2023

Clinical Trial: A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Atopic Dermatitis

Study Type: INTERVENTIONAL


Official Title: A Phase1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

Brief Summary: The primary objective of this study is to evaluate the safety of IMG-007 in adults with moderate-to-severe AD.The secondary objectives are to evaluate the pharmacokinetics and efficacy of IMG-007 in AD patients.

Read more